Search the web
Sign In
New User? Sign Up
nathanfaustmantrials · JoinLeeNow Nathan/Faustman Trials Group
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Want your group to be featured on the Yahoo! Groups website? Add a group photo to Flickr.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
***(involuntary flaw) in the BCG process**   Message List  
Reply | Forward Message #264 of 634 |
Hey Everybody,
 
This is my 2 cents, because I have FULL FAITH that Dr. Faustman is on the right track in her concept of correcting the attack on islets, and resurrecting it. But I think there is a *huge* fly in the ointment. Have faith, ladies and gentleman -- please remember Dr. Faustman is a amazing scientist. I am an amazing diabetic -- and the information I share is one part-frustration (with Big Pharma) and one part faith (the only thing keeping me going)!
 
Two questions for everybody reading:
 
1) After the initial (proposed) BCG treatment phase -- is the insulin type changed from *rDNA human synthetic to highly purified porcine insulin?
 
rDNA *synthetic human insulin increase insulin antibodies vs. highly purified porcine insulin. rDNA synthetic human will continue to destroy islets -- even if the BCG treatment is successful in correcting it (from within).
 
What is $uspiciou$ to me is why BIG PHARMA would market insulin that continues to build antibodies to destroy the natural insulin that MIGHT be trying to make it way out. rDNA.human synthetic insulin is the ONLY type distributed by big pharmaceutical companies in the United States. Highly purified porcine insulin actually *reduces* the insulin antibodies, thus allowing the course of BCG treatment to take effect successfully.
 
2) After the initial BCG treatment phase -- was C-peptide considered in *therapeutic* doses to PROTECT and ENCOURAGE the regrown of Islets?
 
C-peptide plays a significant role in the protection and development of microvascular health. I believe this *could* (need a scientist to test my theory) lend a tremendous upper-hand to correcting the autoimmune attack addressed by the initial BCG treatment phase.
 
C-peptide is found in NATURALLY occurring insulin (nothing a type 1 diabetic has on board). It is a naturally occuring piece of proinsuiln -- that derives from the beta cells. When we produce insulin (51 amino acids in A and B chains) there is a 3rd piece that is called "Connecting Peptide"). This C-peptide has not been included in lab-engineered insulin -- and existed *formerly* in animal derived insulins. Big pharma decided to take it out, and banish the idea of manufacturing *highly purified* porcine insulin. It was cheaper to make rDNA human synthetic. It was also a way to ensure you'd be injecting it for life -- it sustains a higher level of insulin antibodies.
 
Please -- I welcome *any and all* questions pertaining to this procedure. I don't know too much about it-- but I blog about everything PROMISING and FORWARD-THINKING going on in diabetes. Dr. Faustman, without doubt -- deserves the time and appreciation for all she has done, and all it will prove to do for the rest of us living with type 1 diabetes.
 
Thanks to everybody for your feedback!!
 
Best regards,
Allie Beatty




See what's free at AOL.com.


Wed Apr 18, 2007 3:37 pm

allison_beatty
Offline Offline
Send Email Send Email

Forward
Message #264 of 634 |
Expand Messages Author Sort by Date

Hey Everybody, This is my 2 cents, because I have FULL FAITH that Dr. Faustman is on the right track in her concept of correcting the attack on islets, and...
allieb2@...
allison_beatty
Offline Send Email
Apr 19, 2007
10:51 am
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help